Hepatiis antigen and o-fetoprotein in neonatal hepatitis
Of various embryonic proteins, ao-fetoprotein (AFP) has evoked considerable interest through its association with primary hepatocellular and embryonal carcinomas (Abelev, 1968) . Recently, we reported the presence of AFP in 45 % of patients with Indian childhood cirrhosis (Nayak et al., 1972) . In primary hepatoma (Vogel et al., 1970) , as well as in Indian childhood cirrhosis (Chandra, 1970; Chandra et al., 1972) , hepatitis-associated antigen (HAA) was detected in a significantly higher proportion of cases than controls, and it has been postulated that viral hepatitis may predate the development of carcinoma/cirrhosis. In both diseases there is a significant positive correlation between detection of HAA and AFP. We have looked for the presence of AFP and HAA in 24 patients with neonatal hepatitis.
Observations
The diagnosis of neonatal hepatitis was made in 24 infants on the basis of jaundice, hepatomegaly, threeto sixfold rise in serum transaminases, and constitutional symptoms. In 5 patients, a needle biopsy of the liver (ante mortem in 4, post mortem in 1) showed varying degrees of parenchymal cell damage, cholestasis, and inflammatory cell reaction. In 2 specimens giant cell transformation was also seen. There were 15 boys and 9 girls. The age at the time of first examination ranged from 4 to 16 weeks.
HAA was detected by counterimmunoelectrophoresis (Gocke and Howe, 1970) (Fig.) .
All the 24 healthy infants matched for age and sex, and their mothers, were negative for HAA as well as for AFP. The frequency occurrence of HAA in the healthy population in New Delhi is0 -7%0 (Chandra, 1970; Ghandra et al., 1972 (Dailner, Siekevitz, and Palade, 1966) .
The presence of AFP beyond the immediate neonatal period arouses strong suspicion of embryonal carcinoma, primary hepatoma, and Indian childhood cirrhosis, and is believed to be the result of disrupted repressor mechanisms. In hepatic cell carcinoma, there is some correlation between AFP and HAA detection. Our data show that AFP may persist or reappear in detectable amounts in a significant number of patients with neonatal hepatitis. Masopust et al. (1968) reported the presence of AFP in a few infants with 'hepatopathies' but no details were given and quantitation was not attempted. In normal infants beyond 2 weeks of age, Kang et al. (1972) 
